RIGEL PHARMACEUTICALS INC (RIGL) Fundamental Analysis & Valuation

NASDAQ:RIGL • US7665597024

Current stock price

25.81 USD
-0.56 (-2.12%)
At close:
25.81 USD
0 (0%)
After Hours:

This RIGL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. RIGL Profitability Analysis

1.1 Basic Checks

  • RIGL had positive earnings in the past year.
  • RIGL had a positive operating cash flow in the past year.
  • In multiple years RIGL reported negative net income over the last 5 years.
  • In multiple years RIGL reported negative operating cash flow during the last 5 years.
RIGL Yearly Net Income VS EBIT VS OCF VS FCFRIGL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

1.2 Ratios

  • The Return On Assets of RIGL (71.46%) is better than 99.61% of its industry peers.
  • The Return On Equity of RIGL (93.75%) is better than 99.61% of its industry peers.
  • RIGL has a better Return On Invested Capital (23.92%) than 97.88% of its industry peers.
Industry RankSector Rank
ROA 71.46%
ROE 93.75%
ROIC 23.92%
ROA(3y)20.24%
ROA(5y)1.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RIGL Yearly ROA, ROE, ROICRIGL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400

1.3 Margins

  • Looking at the Profit Margin, with a value of 124.72%, RIGL belongs to the top of the industry, outperforming 98.84% of the companies in the same industry.
  • The Operating Margin of RIGL (42.63%) is better than 98.65% of its industry peers.
  • RIGL has a Gross Margin of 93.33%. This is amongst the best in the industry. RIGL outperforms 93.83% of its industry peers.
  • RIGL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 42.63%
PM (TTM) 124.72%
GM 93.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.81%
GM growth 5Y-1.21%
RIGL Yearly Profit, Operating, Gross MarginsRIGL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. RIGL Health Analysis

2.1 Basic Checks

  • RIGL has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for RIGL has been increased compared to 1 year ago.
  • Compared to 5 years ago, RIGL has less shares outstanding
  • The debt/assets ratio for RIGL has been reduced compared to a year ago.
RIGL Yearly Shares OutstandingRIGL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
RIGL Yearly Total Debt VS Total AssetsRIGL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of 1.31, we must say that RIGL is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.31, RIGL is in the better half of the industry, outperforming 63.58% of the companies in the same industry.
  • The Debt to FCF ratio of RIGL is 0.69, which is an excellent value as it means it would take RIGL, only 0.69 years of fcf income to pay off all of its debts.
  • RIGL has a Debt to FCF ratio of 0.69. This is amongst the best in the industry. RIGL outperforms 94.80% of its industry peers.
  • A Debt/Equity ratio of 0.06 indicates that RIGL is not too dependend on debt financing.
  • RIGL has a Debt to Equity ratio (0.06) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.69
Altman-Z 1.31
ROIC/WACC2.45
WACC9.75%
RIGL Yearly LT Debt VS Equity VS FCFRIGL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.42 indicates that RIGL has no problem at all paying its short term obligations.
  • With a Current ratio value of 2.42, RIGL is not doing good in the industry: 71.48% of the companies in the same industry are doing better.
  • RIGL has a Quick Ratio of 2.30. This indicates that RIGL is financially healthy and has no problem in meeting its short term obligations.
  • RIGL has a Quick ratio of 2.30. This is in the lower half of the industry: RIGL underperforms 70.13% of its industry peers.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 2.3
RIGL Yearly Current Assets VS Current LiabilitesRIGL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. RIGL Growth Analysis

3.1 Past

  • RIGL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 593.62%, which is quite impressive.
  • Looking at the last year, RIGL shows a very strong growth in Revenue. The Revenue has grown by 64.15%.
  • Measured over the past years, RIGL shows a very strong growth in Revenue. The Revenue has been growing by 22.06% on average per year.
EPS 1Y (TTM)593.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.75%
Revenue 1Y (TTM)64.15%
Revenue growth 3Y34.78%
Revenue growth 5Y22.06%
Sales Q2Q%21.19%

3.2 Future

  • The Earnings Per Share is expected to decrease by -2.44% on average over the next years.
  • RIGL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.25% yearly.
EPS Next Y-36.48%
EPS Next 2Y-13.06%
EPS Next 3Y-8.59%
EPS Next 5Y-2.44%
Revenue Next Year-3.09%
Revenue Next 2Y4.53%
Revenue Next 3Y6.64%
Revenue Next 5Y6.25%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
RIGL Yearly Revenue VS EstimatesRIGL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
RIGL Yearly EPS VS EstimatesRIGL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 -5

More info and screens

Find the best growth stocksShow best growing peers

8

4. RIGL Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 3.96, the valuation of RIGL can be described as very cheap.
  • 99.04% of the companies in the same industry are more expensive than RIGL, based on the Price/Earnings ratio.
  • RIGL is valuated cheaply when we compare the Price/Earnings ratio to 24.88, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 6.23, which indicates a rather cheap valuation of RIGL.
  • RIGL's Price/Forward Earnings ratio is rather cheap when compared to the industry. RIGL is cheaper than 98.65% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, RIGL is valued rather cheaply.
Industry RankSector Rank
PE 3.96
Fwd PE 6.23
RIGL Price Earnings VS Forward Price EarningsRIGL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • RIGL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. RIGL is cheaper than 99.04% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, RIGL is valued cheaply inside the industry as 98.84% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.3
EV/EBITDA 2.11
RIGL Per share dataRIGL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • RIGL has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as RIGL's earnings are expected to decrease with -8.59% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.06%
EPS Next 3Y-8.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RIGL Dividend Analysis

5.1 Amount

  • No dividends for RIGL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RIGL Fundamentals: All Metrics, Ratios and Statistics

RIGEL PHARMACEUTICALS INC

NASDAQ:RIGL (3/27/2026, 8:00:01 PM)

After market: 25.81 0 (0%)

25.81

-0.56 (-2.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-03
Earnings (Next)05-04
Inst Owners91.09%
Inst Owner Change6.53%
Ins Owners3.09%
Ins Owner Change6.76%
Market Cap476.71M
Revenue(TTM)294.28M
Net Income(TTM)367.02M
Analysts80
Price Target47.94 (85.74%)
Short Float %21.33%
Short Ratio9.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)28.95%
Min EPS beat(2)-9.57%
Max EPS beat(2)67.46%
EPS beat(4)3
Avg EPS beat(4)168.74%
Min EPS beat(4)-9.57%
Max EPS beat(4)592.43%
EPS beat(8)6
Avg EPS beat(8)228.66%
EPS beat(12)10
Avg EPS beat(12)171.43%
EPS beat(16)13
Avg EPS beat(16)137.97%
Revenue beat(2)1
Avg Revenue beat(2)4.83%
Min Revenue beat(2)-0.39%
Max Revenue beat(2)10.05%
Revenue beat(4)3
Avg Revenue beat(4)10.23%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)19.17%
Revenue beat(8)6
Avg Revenue beat(8)10%
Revenue beat(12)10
Avg Revenue beat(12)7.75%
Revenue beat(16)12
Avg Revenue beat(16)11.69%
PT rev (1m)0%
PT rev (3m)3.68%
EPS NQ rev (1m)9.35%
EPS NQ rev (3m)9.35%
EPS NY rev (1m)7.12%
EPS NY rev (3m)-5.83%
Revenue NQ rev (1m)7.25%
Revenue NQ rev (3m)7.25%
Revenue NY rev (1m)1.73%
Revenue NY rev (3m)-2.56%
Valuation
Industry RankSector Rank
PE 3.96
Fwd PE 6.23
P/S 1.62
P/FCF 6.3
P/OCF 6.3
P/B 1.22
P/tB 1.3
EV/EBITDA 2.11
EPS(TTM)6.52
EY25.26%
EPS(NY)4.14
Fwd EY16.05%
FCF(TTM)4.1
FCFY15.87%
OCF(TTM)4.1
OCFY15.87%
SpS15.93
BVpS21.2
TBVpS19.86
PEG (NY)N/A
PEG (5Y)N/A
Graham Number55.76
Profitability
Industry RankSector Rank
ROA 71.46%
ROE 93.75%
ROCE 30.28%
ROIC 23.92%
ROICexc 38.21%
ROICexgc 42.24%
OM 42.63%
PM (TTM) 124.72%
GM 93.33%
FCFM 25.71%
ROA(3y)20.24%
ROA(5y)1.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.81%
GM growth 5Y-1.21%
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.69
Debt/EBITDA 0.18
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage 19.09
Cash Conversion 59.16%
Profit Quality 20.61%
Current Ratio 2.42
Quick Ratio 2.3
Altman-Z 1.31
F-Score6
WACC9.75%
ROIC/WACC2.45
Cap/Depr(3y)409.8%
Cap/Depr(5y)265.74%
Cap/Sales(3y)4.35%
Cap/Sales(5y)2.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)593.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.75%
EPS Next Y-36.48%
EPS Next 2Y-13.06%
EPS Next 3Y-8.59%
EPS Next 5Y-2.44%
Revenue 1Y (TTM)64.15%
Revenue growth 3Y34.78%
Revenue growth 5Y22.06%
Sales Q2Q%21.19%
Revenue Next Year-3.09%
Revenue Next 2Y4.53%
Revenue Next 3Y6.64%
Revenue Next 5Y6.25%
EBIT growth 1Y418.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-24.59%
EBIT Next 3Y32.03%
EBIT Next 5YN/A
FCF growth 1Y143.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y140.4%
OCF growth 3YN/A
OCF growth 5YN/A

RIGEL PHARMACEUTICALS INC / RIGL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of RIGEL PHARMACEUTICALS INC (RIGL) stock?

ChartMill assigns a fundamental rating of 6 / 10 to RIGL.


What is the valuation status for RIGL stock?

ChartMill assigns a valuation rating of 8 / 10 to RIGEL PHARMACEUTICALS INC (RIGL). This can be considered as Undervalued.


Can you provide the profitability details for RIGEL PHARMACEUTICALS INC?

RIGEL PHARMACEUTICALS INC (RIGL) has a profitability rating of 6 / 10.


How financially healthy is RIGEL PHARMACEUTICALS INC?

The financial health rating of RIGEL PHARMACEUTICALS INC (RIGL) is 6 / 10.